A Message from the ESMO President By Ogkologos - March 17, 2020 606 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Belzutifan with Pembrolizumab for Adjuvant Treatment of Renal Cell Carcinoma How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors Adding Belzutifan to Pembrolizumab Prolongs DFS After Nephrectomy in Patients with ccRCC at Increased Risk for Recurrence MOST POPULAR Evaluation of Primary and Secondary Prevention of Oral Cancer October 28, 2022 ESMO-WHO Collaboration in Kazakhstan Yields Evidence-Based Approach for Closing the Gaps... January 31, 2022 FDA Approves Darolutamide Tablets for Metastatic Hormone-Sensitive Prostate Cancer August 16, 2022 ASCO 2023 roundup: Blood tests, drugs and exercise June 12, 2023 Load more HOT NEWS Adding Atezolizumab to mFOLFOX6 Improves DFS Among Patients with Stage III dMMR Colon Cancer Our sun safety messaging tours the UK with the NIVEA Sun... Cancer Prevention Message Is Key for HPV Vaccination Discussions with Parents The IGCCCG Update Model Allows Improved and More Granular Individual Prognostic...
